Founder, Inception Sciences
Founder and Managing Director, Lead Dog Ventures
Co-Founder, Fate Therapeutics
Dir., Mt. Sinai Institute for Genomics and Multi-Scale Biology
Chairman of the New York Angels and Founder of Launch.it
Director, Neurobiotics Laboratory, University of Washington
Founder and CTO, Shopximity
Partner, Latham & Watkins
|
|
If Aveo Oncology has any plans to sell tivozanib as a kidney cancer drug, it’s going to have to do it without Astellas Pharma.
The fallout from the disastrous May 2 FDA advisory panel continues as Cambridge, MA-based Aveo (NASDAQ: AVEO... Read more »
Back in January I got an invitation out of the blue to give a 1-hour talk at the Palo Alto Research Center—the Xerox-owned lab better known as PARC. The invitation was completely open-ended. The full extent of PARC’s guidance was... Read more »
Broad startup initiatives, big acquisitions, critical data readouts, and more characterized the news flowing out of the biotech sector along the East Coast this week. Details below:
—Residents of Long Island, NY, were dismayed when Astellas Pharma shut down their local... Read more »
It’s not often that you’ll find a company with six cancer drugs in clinical trials that have their own companion diagnostics, and an in-house drug discovery engine. So why all the skepticism surrounding Merrimack Pharmaceuticals?
After going public in March 2012... Read more »
When Twitter landed in Boston earlier this year it didn’t mess around, spending around $200 million for two startups. And we’re starting to see more of the payoff for that expensive shopping trip.
Today, as part of its efforts to... Read more »
TechStars Boston has officially unleashed its latest group of early stage companies, 14 startups with well-practiced pitches and big hopes. And this time around, several companies stood out for their focus on tackling real-world problems with software and online tools.... Read more »
Among local startups, Digital Lumens is a different kind of animal. It’s a hardware company. It’s a networking software company. It’s an energy-efficiency company. It’s an LED and “smart lighting” company. So what is it?
Well, all of the above. Interestingly,... Read more »
With just under a month to go before our fifth annual XSITE conference at Babson College (agenda here), we’re pleased to announce that CommonAngels has pledged to buy 20 tickets for startups looking to attend—see below for details. (CommonAngels... Read more »
Ironwood Pharmaceuticals and NPS Pharmaceuticals have plenty in common: both won FDA approval of their first drugs in 2012, and both are trying to prove to investors that they can successfully sell them. And now, both have sought out Wall Street... Read more »
[Updated 12:55 pm] A CEO swap, some corporate M&A, student entrepreneurship, increased sales numbers, fundraising, and general deal-making in this quick trip through some Boston-area innovation headlines:
—Mobile advertising startup Adelphic is getting a new leader. The company says... Read more »
A bit of friendly rivalry is healthy for cities with growing technology ecosystems, but sometimes they set aside the hype and find ways to collaborate. At the onset of this week’s Internet Week New York citywide festivities, representatives from 11 cities... Read more »
Don’t look now, but Swipely is becoming a big player.
The Providence, RI-based startup led by Angus Davis (of Tellme Networks fame) has just raised $12 million in Series B funding led by Shasta Ventures. Previous investors First Round Capital, Greylock... Read more »
What are the most powerful forces affecting innovation and the economy? That is one of the key questions facing the nation as we inch our way out of the economic mire.
Juan Enriquez may not have all the answers, but he... Read more »
Karyopharm Therapeutics believes it can build a platform of cancer drugs off of the idea of keeping the body’s tumor-suppressing proteins in the nucleus of cells, where they can do their jobs properly. With the help of a new $48.2 million... Read more »
David Karp’s wallet just got a lot fatter.
After a flurry of speculation over the weekend, Tumblr in New York is being acquired by Sunnyvale, CA-based Yahoo, in a deal announced early Monday at the previously reported price of $1.1 billion,... Read more »
I’m on the phone with Andy Miller, and I don’t know where to begin.
Ask him about working with Steve Jobs at Apple? About how Leap Motion may or may not be the next Apple? Or what about how that $348... Read more »
Biotech industry conferences are happening, somewhere on this green Earth, every day. If you’ve been around a while, and you’ve attended a few, chances are you get invitations, or marketing pitches, that ask you to attend a different meeting every day.... Read more »
A smattering of fundraising announcements involving Boston-area companies and investors, along with a student entrepreneurship program in this collection of local news tidbits:
—Skyword, a Boston-based marketing company that links freelance copywriters with advertisers and other clients, has raised... Read more »
I was pretty slow about getting around to reading Thinking, Fast and Slow. The career-capping book by Princeton psychologist Daniel Kahneman, one of the founders of behavioral economics, spent months on all the bestseller lists back in 2011. I finally... Read more »
Founder and CEO of Wolfram Research
Professor of Genetics, Harvard Medical School
Scientist and Managing Dir., Microsoft Research New England
Professor of Leadership, Emeritus at the Harvard Business School
Executive VP of R&D, Biogen Idec
President Emeritus, MIT
General Partner, Flybridge Capital Partners
Instructor in Pediatrics, Harvard Medical School
Associate Professor of Media Arts and Sciences, MIT
Professor, MIT
San Francisco · 6/3/13
Xconomy offers a number of ways to subscribe for free!
Subscribe Now
